Company Filing History:

15 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

2 out of 272

Kyowa Hakko Kirin Co., Limited

Years Active: 1989-2010

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7708999 - Remedies for arthritis (2010-05-04),

2. 7691367 - Branched polyalkylene glycols (2010-04-06),

3. 7524852 - Bicyclic pyrimidine derivatives (2009-04-28),

4. 6376535 - Oxygen-containing heterocyclic compounds (2002-04-23),

5. 5319085 - Quinoline derivative having serotonin-3 receptor antagonizing activity (1994-06-07),

6. 5302602 - Tricyclic thromboxane A.sub.2 antagonists (1994-04-12),

7. 5302596 - Tricyclic compounds as TXA.sub.2 antagonists (1994-04-12),

8. 5248684 - Certain 2-oxo-quinoline carboxylates or corresponding carboxamides (1993-09-28),

9. 5242931 - Tricyclic compounds as TXA.sub.2 antagonists (1993-09-07),

10. 5155115 - Thienopyridine derivatives (1992-10-13),

11. 5143922 - Tricyclic thromboxane A.sub.2 antagonists (1992-09-01),

12. 5118701 - Tricyclic compounds as TXA.sub.2 antagonists (1992-06-02),

13. 5010104 - Tricyclic compounds (1991-04-23),

14. 5010087 - Tricyclic compounds and TXA.sub.2 antagonistic compositions thereof (1991-04-23),

15. 4999363 - Tricyclic compounds (1991-03-12),

Title: Ichiro Miki: Innovator in Arthritis Treatment and Polyalkylene Glycols

Introduction

Ichiro Miki is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of medical treatments and chemical modifications, holding a total of 18 patents. His work focuses on innovative solutions for arthritis and the development of branched polyalkylene glycols.

Latest Patents

One of Miki's latest patents addresses remedies for arthritis. This invention provides an agent for preventing or treating arthritis, which includes a cartilage protecting agent, a joint destruction inhibitor, and a synovial membrane growth inhibitor. The active ingredient in this invention is an anti-FGF-8 neutralizing antibody. Additionally, he has developed a diagnostic agent for arthritis that comprises an anti-FGF-8 antibody and a method for judging arthritis using this antibody. Another significant patent involves branched polyalkylene glycols, which are useful as chemically modifying agents for physiologically active polypeptides. This invention links two single-chain polyalkylene glycols to a cyclic structure, enhancing their reactivity with amino acid side chains and other functional groups in polypeptides.

Career Highlights

Ichiro Miki has worked with notable companies such as Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions in his field.

Collaborations

Miki has collaborated with several professionals, including Akio Ishii and Akira Karasawa. These collaborations have likely enriched his research and development efforts.

Conclusion

Ichiro Miki's contributions to the fields of arthritis treatment and chemical modifications demonstrate his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to advancing medical science and technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.